Ecstasy use and higher-level cognitive functions: weak effects of ecstasy after control for potential confounds

被引:39
作者
Bedi, G. [1 ]
Redman, J. [1 ]
机构
[1] Monash Univ, Dept Psychol, Melbourne, Vic 3004, Australia
关键词
cannabis; cognition; ecstasy; memory; polydrug;
D O I
10.1017/S0033291708002730
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Background. Although there have been several reports linking ecstasy use with lowered cognitive function, much previous research suffers from substantial methodological limitations. The present study aimed to examine associations between ecstasy use and higher-level cognitive functions, using a larger sample size than most previous research and better controlling for a range of potential confounds. Method. A cross-sectional cohort design assessed 45 currently abstinent ecstasy polydrug users (EP), 48 cannabis polydrug users (CP) and 40 legal drug users (LD). Standardized neuropsychological tests were used to measure attention, verbal, visual and working memory and executive function. Prospective memory function was also assessed. Results. It was not possible to discriminate between groups on the basis of the cognitive functions assessed. Regression analyses showed an inverse association between lifetime dose of ecstasy and verbal memory performance. A combination of drug-use variables, including measures of ecstasy use, contributed to prediction of attention/working memory. However, individual associations were small, explaining 1-6% of variance in cognitive scores. Conclusions. Although the results suggest that heavy use of ecstasy is associated with some lowering of higher-level cognitive functions, they do not indicate a clinical picture of substantial cognitive dysfunction.
引用
收藏
页码:1319 / 1330
页数:12
相关论文
共 49 条
[11]   Auditory verbal learning in drug-free Ecstasy polydrug users [J].
Fox, HC ;
Toplis, AS ;
Turner, JJD ;
Parrott, AC .
HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL, 2001, 16 (08) :613-618
[12]   Neuropsychological evidence of a relatively selective profile of temporal dysfunction in drug-free MDMA ("ecstasy") polydrug users [J].
Fox, HC ;
McLean, A ;
Turner, JJD ;
Parrott, AC ;
Rogers, R ;
Sahakian, BJ .
PSYCHOPHARMACOLOGY, 2002, 162 (02) :203-214
[13]   Executive cognitive functioning and risk for substance abuse [J].
Giancola, PR ;
Tarter, RE .
PSYCHOLOGICAL SCIENCE, 1999, 10 (03) :203-205
[14]   Memory performance in polyvalent MDMA (ecstasy) users who continue or discontinue MDMA use [J].
Gouzoulis-Mayfrank, E ;
Fischermann, T ;
Rezk, M ;
Thimm, B ;
Hensen, G ;
Daumann, J .
DRUG AND ALCOHOL DEPENDENCE, 2005, 78 (03) :317-323
[15]   Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) [J].
Gouzoulis-Mayfrank, E ;
Daumann, J ;
Tuchtenhagen, F ;
Pelz, S ;
Becker, S ;
Kunert, HJ ;
Fimm, B ;
Sass, H .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (06) :719-725
[16]   Memory impairment suggests hippocampal dysfunction in abstinent ecstasy users [J].
Gouzoulis-Mayfrank, E ;
Thimm, B ;
Rezk, M ;
Hensen, G ;
Daumann, J .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2003, 27 (05) :819-827
[17]   Residual neuropsychological effects of illicit 3,4-methylenedioxymethamphetamine (MDMA) in individuals with minimal exposure to other drugs [J].
Halpern, JH ;
Pope, HG ;
Sherwood, AR ;
Barry, S ;
Hudson, JI ;
Yurgelun-Todd, D .
DRUG AND ALCOHOL DEPENDENCE, 2004, 75 (02) :135-147
[18]   Effects of brain injury and age on prospective memory self-rating and performance [J].
Hannon, R ;
Adams, P ;
Harrington, S ;
FriesDias, C ;
Gipson, MT .
REHABILITATION PSYCHOLOGY, 1995, 40 (04) :289-298
[19]   Neurocognitive function in current and ex-users of ecstasy in comparison to both matched polydrug-using controls and drug-naive controls [J].
Hoshi, Rosa ;
Mullins, Kate ;
Boundy, Catherine ;
Brignell, Catherine ;
Piccini, Paula ;
Curran, H. Valerie .
PSYCHOPHARMACOLOGY, 2007, 194 (03) :371-379
[20]   Preliminary evidence of hippocampal dysfunction in adolescent MDMA ("ecstasy") users: possible relationship to neurotoxic effects [J].
Jacobsen, LK ;
Mencl, WE ;
Pugh, KR ;
Skudlarski, P ;
Krystal, JH .
PSYCHOPHARMACOLOGY, 2004, 173 (3-4) :383-390